Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1976 1
1998 2
1999 1
2000 2
2001 4
2002 1
2003 2
2005 2
2006 2
2007 1
2008 1
2009 2
2010 2
2011 4
2012 4
2013 4
2014 3
2016 5
2017 10
2018 10
2019 7
2020 7
2021 4
2023 1
2024 2
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
Ofatumumab versus Teriflunomide in Multiple Sclerosis.
Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L; ASCLEPIOS I and ASCLEPIOS II Trial Groups. Hauser SL, et al. N Engl J Med. 2020 Aug 6;383(6):546-557. doi: 10.1056/NEJMoa1917246. N Engl J Med. 2020. PMID: 32757523 Clinical Trial.
Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP).
Butzkueven H, Kappos L, Wiendl H, Trojano M, Spelman T, Chang I, Kasliwal R, Jaitly S, Campbell N, Ho PR, Licata S; Tysabri Observational Program (TOP) Investigators. Butzkueven H, et al. J Neurol Neurosurg Psychiatry. 2020 Jun;91(6):660-668. doi: 10.1136/jnnp-2019-322326. Epub 2020 Mar 31. J Neurol Neurosurg Psychiatry. 2020. PMID: 32234967 Free PMC article.
Serum Alpha-Linolenic Acid and Long-Term Multiple Sclerosis Activity and Progression.
Cortese M, Peng X, Edan G, Freedman MS, Hartung HP, Montalban X, Sandbrink R, Radü EW, Barkhof F, Wicklein EM, Kappos L, Ascherio A, Bjornevik K; BENEFIT Study Group. Cortese M, et al. Neurology. 2025 Aug 12;105(3):e213905. doi: 10.1212/WNL.0000000000213905. Epub 2025 Jul 17. Neurology. 2025. PMID: 40674673 Clinical Trial.
Transcranial magnetic stimulation in disorders of consciousness.
Lapitska N, Gosseries O, Delvaux V, Overgaard M, Nielsen F, Maertens de Noordhout A, Moonen G, Laureys S. Lapitska N, et al. Among authors: delvaux v. Rev Neurosci. 2009;20(3-4):235-50. doi: 10.1515/revneuro.2009.20.3-4.235. Rev Neurosci. 2009. PMID: 20157993 Review.
[Pathophysiology, assessment and treatment of laryngopharyngeal reflux].
Lechien JR, Khalife M, Delvaux V, Huet K, Piccaluga M, Costa de Araujo P, Harmegnies B, Saussez S. Lechien JR, et al. Among authors: delvaux v. Rev Laryngol Otol Rhinol (Bord). 2014;135(4-5):163-70. Rev Laryngol Otol Rhinol (Bord). 2014. PMID: 26521362 Review. French.
Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome.
Maillart E, Vidal JS, Brassat D, Stankoff B, Fromont A, de Sèze J, Taithe F, Clavelou P, Bourre B, Delvaux V, Rico A, Labauge P, Tourbah A, Lebrun C, Pelletier J, Moreau T, Louapre C, Lubetzki C, Papeix C. Maillart E, et al. Among authors: delvaux v. Neurol Neuroimmunol Neuroinflamm. 2017 Apr 14;4(3):e346. doi: 10.1212/NXI.0000000000000346. eCollection 2017 May. Neurol Neuroimmunol Neuroinflamm. 2017. PMID: 28616447 Free PMC article.
78 results